“Ampersand has worked with That’s Nice since 2014 across a number of companies in our life science portfolio. Now we’re leveraging their specialized life science expertise to reinvigorate the Ampersand brand itself.”
Geoffrey P. Teillon, Partner, Ampersand Capital Partners
“That’s Nice’s commitment to our success is evident in every step of our partnership. Their strategic guidance has allowed us to enhance our capabilities and drive innovation, such as in The Solubility Company. The substantial investment and support from their team have been game-changing for Microsize, supporting us in adopting new particle sizing technologies. ”
Derek Hennecke, Chairman of the Board, Microsize
“I’ve known Nigel for 20 years and have been working with That’s Nice for four. Our collaborations have consistently driven our projects forward. Their strategic insights into the biologics market, paired with their creative approach and out-of-the-box thinking, have helped us to align our operations more closely with the evolving needs of our clients.”
Nick Green, CEO, Avid Bioservices
“After being introduced to That’s Nice by Gustavo Mahler, they documented our facility in Buenos Aires and supported us in developing content aimed at English-speaking audiences. This has been instrumental in helping us bring biosimilars to underserved markets.”
Santiago García Belmonte, President, Biosidus
“That’s Nice played a tremendous role in making the Wheeler Bio brand what it is today. Their deep industry knowledge, strategic approach to marketing, and commitment to partnering have proven invaluable to us, from the brand’s inception through to the launch of our clinical-scale manufacturing facility.”
Jesse McCool, Co-Founder & CEO (2020-2024), Wheeler Bio
“The That’s Nice team has proven to be an invaluable partner for several of our portfolio companies. When we merged three organizations to create a unified advanced modalities CRO, That’s Nice expertly spearheaded the development of the new ProtaGene brand. Their consistent delivery of high-quality results across multiple projects has solidified their status as a trusted collaborator.”
Marina Pellón-Consunji, Partner, Ampersand Capital Partners
“When I was first introduced to That’s Nice, I thought “That’s a funny name for a company, what do they do?” However, they helped us successfully rebrand Capsugel prior to our acquisition by Lonza in 2016. It was a collaborative team effort with Nigel and Mark really complementing and challenging our views of the business.”
James (Jim) Coward, VP, Marketing – Mammalian & Microbial Development & Manufacturing, (Lonza)
“The innovative thinking, commitment, and creativity we have gotten from That’s Nice over the years have helped me to implement and deliver on my vision as CEO of Alcami.”
Stephan Kutzer, Ph.D., President & CEO (2014-2019), Alcami
“When we hired That’s Nice 10 years ago. We had one request – to put BioVectra on the map, and they did. We are proud of the work they have done for us.”
Oliver Technow, CEO, BioVectra
“For many years, I have turned to That’s Nice for their industry expertise and strategic support. Their deep industry knowledge, extensive network, and resources have made That’s Nice an invaluable partner.”
Daniella Kranjac, Founding GP, Venture Capital Firm
“That’s Nice has supported us for over two decades – from our early days at Aerojet to our transition to AMPAC Fine Chemicals. Recently, AMPAC Fine Chemicals was acquired by SK Holdings, leading to the formation of SK pharmteco. With exciting times ahead, we look forward to many more years of success with That’s Nice as we evolve into an integrated, global CDMO.”
Aslam Malik, CEO (2016-2019), Ampac Fine Chemicals (SK pharmteco)
“That’s Nice has worked with me on three consecutive companies I have launched over eight years. We’ve made acquisitions along the way and the first two companies were themselves acquired. The caliber of industry experience and knowledge at That’s Nice really sets the company apart as an agency and consultant, which has been invaluable with each of my ventures.”
Mark Bamforth, President & CEO (2019-2022), Arranta Bio
“That’s Nice has totally disrupted the traditional agency business model. Nigel and his great team provide really valuable research and M&A consulting services unlike most agencies.”
Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma
“That’s Nice has been a value-added partner to Signet Healthcare, providing us with ongoing industry knowledge and competitive intelligence. Their strategic insights and commitment to supporting our growth have made a significant impact, ensuring that we are always well-positioned to navigate the complexities of our industry.”
Nikhil Puri, Managing Director, Signet Healthcare Partners
“That’s Nice has supported us on our growth path from a first mover into a promising niche in the pharma industry to a company ready to scale. For instance, when we needed to establish a board of directors after our recent fundraising round, That’s Nice stepped up to the challenge. Their network and industry expertise proved invaluable as they assisted us in identifying and securing a key board member.”
Michael Sokolov, COO, DataHow AG
“That’s Nice has supported multiple portfolio companies over the years, creating world-class branding, messaging, and content that has added significant value. Congratulations on 30 years!”
David Anderson, General Partner, Ampersand Capital Partners
“For more than 11 years, That’s Nice has supported Federal Equipment Company in both strategic and creative capacities, and we look forward to continuing to grow together.”
Adam Covitt, President, Federal Equipment Company
“Having been in the pharmaceutical market for over 40 years, I’ve chosen That’s Nice to work on the last two companies I’ve built from the ground up. They are a group of highly competent, experienced and customer-focused professional who continue to make a major contribution to our success.”
Tim Tyson, Chairman & CEO, TriRx Pharmaceutical Services
“For the past 12 years, I have spoken with the team at That’s Nice on a weekly, if not daily, basis. Their Insight and unprecedented intelligence in the CDMO industry, allows me to make informed decisions. Their delivery supports my growth.”
Russell Harris, Founder & Managing Director, K-CRAB Pharma Services
“That’s Nice has been a tremendous partner to Genezen in my time as CEO, and in prior companies I was a part of in various leadership roles as we built and scaled businesses. They know the CDMO space better than most firms, and can really partner with their customers to drive creative branding, website rebuilds, and PR strategies that drive customer acquisition and engagement. ”
Steve Favaloro, Chairman & CEO, Genezen
“I met Nigel 27 years ago. I was with one of the first companies to give business to That’s Nice. They have now evolved into a multi-faceted marketing agency, serving clients across the entire pharma and biotech space. I continue to work with them today.”
Joe Carleone, Founder & Managing Director, Carleone Partners
“I’ve worked with That’s Nice across a number of companies, and their expertise is second to none. Nigel and his team are my immediate go-to for branding, scientific content, and strategic marketing.”
David Halverson, President & CEO, Prolytix
“That’s Nice has been an invaluable partner on our journey. During Wheeler Bio’s Series A fundraising, we turned to That’s Nice for strategic support. Through their insights and network, they played a key role in the successful completion of the $31 million raise, helping to secure the capital necessary to drive Wheeler Bio’s next phase of expansion.”
Jesse McCool, Co-Founder & CEO, Wheeler Bio
“To say That’s Nice is the pharma industry’s premier agency is an understatement. I’ve collaborated with them across three companies, and will continue to do so for years to come.”
Hank Nowak, Vice President, Commercial Development (2023-2024)
“The work That’s Nice performed for Scorpius during our company’s rebranding speaks volumes about their team’s talent and strategic prowess. They designed for us a go-to-market strategy that not only elevated awareness for our brand at a pivotal juncture, but also ensured Scorpius became a household name among key decision-makers, all underpinned by an unforgettable launch event at DCAT. Together, we made something extraordinary.”
Jeff Wolf, Founder, Chairman & CEO, Scorpius BioManufacturing
